.png){kind=icon}
返回
Intralymphatic immunotherapy
.png){kind=icon}
OA
AI
DOI：10.1186/s40413-014-0047-7.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Gold Standard allergen-specific immunotherapy is associated with low efficacy because it requires either many subcutaneous injections of allergen or even more numerous sublingual allergen administrations to achieve amelioration of symptoms. Intralymphatic vaccination can maximize immunogenicity and hence efficacy. We and others have demonstrated that as few as three low dose intralymphatic allergen administrations are sufficient to effectively alleviate symptoms. Results of recent prospective and controlled trials suggest that this strategy may be an effective form of allergen immunotherapy.
Keyword:
Administration routes
Allergen immunotherapy
Intralympathic
Vaccination
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
4.3
论文数:
1.2K
被引数:
4.1K
机构
引用论文
Influence of Fuel Injection Timing Over the Performances of a Direct Injection Spark Ignition Engine
PREAI
分享收藏分享收藏Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines.png)
ALLERGYOAAI
ALLERGYIF12
OAAI分享收藏
分享收藏
查看更多内容